FDA
approval
· 2010-06-04
FDA Approved: METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for the generic fixed-dose combination of metoprolol tartrate and hydrochlorothiazide, manufactured by Mylan.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE (METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE)